Inflammation News and Research

RSS

New study pinpoints neurons that slow us down during sickness

We tend to eat, drink, and move less when we're feeling under the weather. And we're not alone - most animals reduce those same three behaviors when they're fighting an infection.

27 Oct 2022

Long COVID, a new clinical entity constantly evolving

Researchers discuss the epidemiology, diagnosis, pathogenesis, and treatment of long COVID.

27 Oct 2022

Studies find cardiovascular effects of cigarettes and e-cigarettes to be strikingly similar

Two related studies, one in humans and the other in rats, found that the cardiovascular effects of cigarettes and e-cigarettes are strikingly similar, and these harmful effects on blood vessel function are likely caused by airway irritation due to inhalation of a foreign substance, rather than a specific component of the cigarette smoke or e-cigarette vapor (aerosol), according to new research published today in the American Heart Association's peer-reviewed journal Arteriosclerosis, Thrombosis and Vascular Biology.

27 Oct 2022

Cells in the brain's blood vessels necessary for fever reaction

Researchers at Linköping University have identified in mice the cells in the blood vessels of the brain that are necessary for a fever reaction.

26 Oct 2022

First-time sexual intercourse associated with increases in vaginal immune activity in young women

The changes detected may have important implications for sexually transmitted infection (STI) risk. But the authors do not yet know if the changes increase or decrease the risk of acquiring an STI.

26 Oct 2022

One Medicine: how human and veterinary medicine can benefit each other

News-Medical speaks to Professor Roberto La Ragione, Chair of Trustees at Humanimal Trust, about the concept of One Medicine and how human and veterinary medicine can collaborate, share knowledge, and initiate research for the benefit of both humans and animals.

26 Oct 2022

Probiotics and prebiotics can reduce the risk of frailty syndrome among the elderly

New research found that the intestinal microbiome plays a critical role in the metabolic processes that affect cognition, body composition, and immune function.

26 Oct 2022

COVID-19 and the gut

Researchers summarize current knowledge about underlying mechanisms and potential therapeutic approaches for the effects of COVID-19 on the gut.

26 Oct 2022

Study finds new drug combination to be more effective against complicated urinary tract infections

An international study led by a Rutgers scientist comparing new and older treatments against complicated urinary tract infections has found a new drug combination to be more effective, especially against stubborn, drug-resistant infections.

25 Oct 2022

Study identifies an animal model that shares many similarities with progressive MS

A new study from UCLA researchers identified an animal model that could be used to study treatments for improving disabilities in multiple sclerosis patients.

25 Oct 2022

RIT professor receives grant to investigate new therapeutic approaches for scleroderma

More collagen in the human body is not always good, and Karin Wuertz-Kozak is investigating how disease progresses because of the increase in this important protein.

25 Oct 2022

Researchers identify specific T cell required to bolster vaccine immunity against fungal pneumonia

Researchers at the University of Illinois College of Veterinary Medicine have demonstrated in a mouse model that a specific type of T cell, one of the body's potent immune defenses, produces cytokines that are necessary for the body to acquire immunity against fungal pathogens.

25 Oct 2022

Harmless group of bacteria linked with increased risk of death in patients with end-stage renal disease

A big group of bacteria found in our soil, our water and our showerheads are harmless for most of us, but a new study indicates they are associated with an increased risk of dying in individuals whose kidneys have failed.

25 Oct 2022

Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

Researchers explored the impact of the coronavirus disease 2019 (COVID-19) pandemic-associated non-pharmaceutical prevention measures on the transmission of 22 infectious diseases in England.

25 Oct 2022

Study reveals how SARS-CoV-2 infection of macrophages promotes inflammatory responses

Dysregulation of macrophages during SARS-CoV-2 infection and the over-exuberant production of pro-inflammatory cytokines by these macrophages has been hypothesized to contribute to severity of COVID-19 disease.

25 Oct 2022

Researchers study the effects of alcohol intake and seek better treatment for alcoholic pancreatitis

Many alcoholic pancreatitis patients continued drinking during COVID-19. University of Miami Miller School of Medicine researchers study the effects of continued alcohol intake and seek better treatment for alcohol-associated pancreatic disease.

24 Oct 2022

Heart attack death rates took a sharp turn and increased during the pandemic, study shows

New data analysis from the Smidt Heart Institute at Cedars-Sinai found that deaths from heart attacks rose significantly during pandemic surges, including the COVID-19 Omicron surges, overall reversing a heart-healthier pre-pandemic trend.

24 Oct 2022

New diagnostic method applies machine learning to advanced genomics data to detect sepsis

Sepsis, the overreaction of the immune system in response to an infection, causes an estimated 20% of deaths globally and as many as 20 to 50% of U.S. hospital deaths each year.

24 Oct 2022

Scientists use systems biology approach to identify molecular players in rheumatoid arthritis

Using a novel systems biology approach, scientists at University of California San Diego School of Medicine have further parsed the cellular players and roles involved in rheumatoid arthritis (RA), a complex disease that affects more than one million Americans in ways that have defied development of uniform treatments.

24 Oct 2022

Regular statin use may reduce the risk of death and severity of COVID-19

Commonly used cholesterol-lowering statins may reduce the risk of death and severity of COVID-19 disease, suggests a study of more than 38,000 patients being presented at the ANESTHESIOLOGY 2022 annual meeting.

24 Oct 2022

Inflammation News and Research

New study pinpoints neurons that slow us down during sickness

Long COVID, a new clinical entity constantly evolving

Studies find cardiovascular effects of cigarettes and e-cigarettes to be strikingly similar

Cells in the brain's blood vessels necessary for fever reaction

First-time sexual intercourse associated with increases in vaginal immune activity in young women

One Medicine: how human and veterinary medicine can benefit each other

Probiotics and prebiotics can reduce the risk of frailty syndrome among the elderly

COVID-19 and the gut

Study finds new drug combination to be more effective against complicated urinary tract infections

Study identifies an animal model that shares many similarities with progressive MS

RIT professor receives grant to investigate new therapeutic approaches for scleroderma

Researchers identify specific T cell required to bolster vaccine immunity against fungal pneumonia

Harmless group of bacteria linked with increased risk of death in patients with end-stage renal disease

Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

Study reveals how SARS-CoV-2 infection of macrophages promotes inflammatory responses

Researchers study the effects of alcohol intake and seek better treatment for alcoholic pancreatitis

Heart attack death rates took a sharp turn and increased during the pandemic, study shows

New diagnostic method applies machine learning to advanced genomics data to detect sepsis

Scientists use systems biology approach to identify molecular players in rheumatoid arthritis

Regular statin use may reduce the risk of death and severity of COVID-19

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News